GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medpace Holdings MEDP · USD

Health Care · US listing · 🇺🇸 United States

Compare

672.93

+3.03%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.53bn

FY2016FY2025

Net income

$451.1m

FY2016FY2025

Free cash flow

$681.9m

FY2016FY2025

Shareholders' equity

$459.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.53bn$2.11bn$1.89bn$1.46bn$1.14bn$925.9m$861.0m$704.6m$436.2m$421.6m
Gross profit$760.6m$656.3m$524.5m$432.4m$328.2m$278.7m$245.7m$215.5m$174.7m$172.1m
Operating income$534.9m$446.9m$336.8m$281.6m$198.7m$167.0m$127.3m$101.0m$64.9m$52.5m
Net income$451.1m$404.4m$282.8m$245.4m$181.8m$145.4m$100.4m$73.2m$39.1m$13.4m
Diluted earnings per share15.5812.638.897.574.823.862.651.971.040.33

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.98bn$2.10bn$1.66bn$1.35bn$1.66bn$1.39bn$1.14bn$967.9m$950.7m$979.1m
Cash and short-term investments$497.0m$669.4m$245.4m$28.3m$461.3m$277.8m$131.9m$23.3m$26.5m$37.1m
Total liabilities$1.52bn$1.28bn$1.10bn$966.1m$707.0m$584.9m$416.8m$378.2m$447.2m$368.4m
Debt———$50.0m———$104.2m$248.2m$192.2m
Shareholders' equity$459.1m$825.5m$559.0m$386.4m$952.9m$805.8m$726.3m$589.7m$503.5m$610.7m
Shares outstanding29m32m32m32m38m38m38m37m38m41m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$713.2m$608.8m$433.4m$388.1m$263.3m$258.7m$201.9m$156.6m$97.4m$91.7m
Capital spending−$31.4m−$36.5m−$36.6m−$36.9m−$28.3m−$31.3m−$17.9m−$16.0m−$12.3m−$13.5m
Free cash flow$681.9m$572.3m$396.7m$351.2m$235.1m$227.3m$184.0m$140.6m$85.1m$78.2m
Dividends paid——−$11.4m−$22.1m——————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$707.3m$706.6m$708.5m$659.9m$603.3m$558.6m$536.6m$533.3m
Gross profit$201.6m$196.3m$205.3m$196.9m$180.0m$178.3m$178.3m$169.0m
Operating income$146.8m$141.5m$153.3m$141.8m$126.3m$113.5m$125.4m$112.3m
Net income$121.4m$123.9m$135.1m$111.1m$90.3m$114.6m$117.0m$96.4m
Diluted earnings per share4.224.314.673.843.123.963.663.01
Cash from operations$162.0m$151.0m$192.0m$246.0m$148.0m$125.0m$190.0m$149.0m
Capital spending−$6.0m−$6.0m−$4.0m−$16.0m−$6.0m−$9.0m−$7.0m−$10.0m
Free cash flow$156.0m$145.0m$188.0m$230.0m$142.0m$116.0m$183.0m$139.0m
Total assets$2.06bn$2.13bn$1.98bn$1.75bn$1.57bn$1.90bn$2.10bn$2.08bn
Cash and short-term investments$502.7m$652.7m$497.0m$285.4m$46.3m$441.4m$669.4m$656.9m
Debt—$23.8m$23.2m$24.9m$24.9m$23.7m$23.3m$23.6m
Shareholders' equity$433.9m$598.3m$459.1m$293.6m$172.4m$593.6m$825.5m$881.4m

Financial ratios

Data as of 3 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin30.1%31.1%27.8%29.6%28.7%30.1%—
Operating margin21.1%21.2%17.9%19.3%17.4%18.0%—
Net margin17.8%19.2%15.0%16.8%15.9%15.7%—
Return on equity98.3%49.0%50.6%63.5%19.1%18.0%—
Return on assets22.8%19.2%17.1%18.1%11.0%10.5%—
Free cash flow yield4.3%3.4%2.5%2.2%1.3%1.3%—
Revenue growth20.0%11.8%29.2%27.8%23.4%7.5%—
Earnings growth11.6%43.0%15.3%34.9%25.1%44.7%—
Current ratio0.74x0.93x0.64x0.42x1.24x1.08x—
Debt to equity0.05x0.03x0.52x0.13x0.17x0.17x—
Equity ratio23.2%39.3%33.7%28.6%57.4%57.9%—
Interest coverage—17.88x690.22x96.94x1892.57x544.11x81.16x
Buybacks as a share of market value9.5%-0.6%1.8%14.1%-0.2%0.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.1%22.3%21.6%
Operating income23.8%26.2%38.5%
Net income22.5%25.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin30.5%29.7%29.6%30.7%
Operating margin21.2%20.0%19.6%18.2%
Net margin18.4%17.3%17.0%15.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings36.126.334.528.145.236.031.726.935.0109.2
Price to sales6.45.05.24.77.25.73.72.83.13.5

Market value over time

30 Nov 2016 to 2 Oct 2026, in USD

$1.34bn$17.24bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return69%8%52%-6%53%65%70%34%4%29%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.